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Impact Of Intraaortic Balloon Pump On 30-Day Mortality In Cardiogenic Shock
AMI Patients With Unsuccessful And Successful Primary PCI - Analysis From
PL-ACS Registry
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Background: Recently, usefulness of intraaortic balloon pump (IABP) for patients
with acute myocardial infarction (AMI) and cardiogenic shock (CS) is questioned.
Therefore we analysed inﬂuence of IABP in CS AMI patients with unsuccessful and
successful primary PCI on 30-day mortality.
Methods: We analysed 4211 patients with CS and AMI from nationwide PL-ACS
registry. Unsuccessful PCI was deﬁned as ﬁnal TIMI ﬂow grade 0 or 1.
Results: Patients with unsuccessful PCI comprised 13.5% (table). In both unsuc-
cessful and successful PCI groups 20% of patients had IABP support and these
patients were of the higher risk proﬁle. IABP was associated with lower 30-day
mortality in unsuccessful PCI group while with higher in successful PCI group. After
adjustment in multivariate Cox proportional model regression IABP remained
signiﬁcantly associated with reduction of 30-day mortality in patients with unsuc-
cessful PCI (HR ¼ 0.71, 95%CI ¼ 0.55-0.91, p¼0.0065) and increased mortality in
patients with successful PCI (HR ¼ 1.26, 95%CI ¼ 1.13-1.43, p<0.0001).Unsuccessful PCI
(ﬁnal TIMI ﬂow 0 or 1)
N=569 (13.5%)
Successful PCI
(ﬁnal TIMI ﬂow 2 or 3)
N=3642 (86.5%)
No IABP IABP P value No IABP IABP P value
Number of patients, n (%) 457 (80%) 112 (20%) 2919 (80%) 723 (20%)
Mean age,
years  SD
70  12 67  11 0.0049 66  12 66  12 0.89
Female sex, % 43 38 0.71 36 33 0.24
Diabetes, % 29 41 0.015 26 31 0.0093
Prior myocardial
infarction, %
20 21 0.72 15 20 0.0004
Cardiac arrest before
admission, %
19 13 0.15 21 18 0.11
Systolic pressure on
admission, %
79  37 81  27 0.46 88  34 83  29 0.0003
Mean heart rate on
admission, %
89  33 88  28 0.89 83  31 91  30 <0.0001
STEMI, % 83 88 0.17 85 83 0.16
Left ventricle ejection
fraction, %
31  13 26  12 0.017 39  13 31  12 <0.0001
TIMI ﬂow 0 or 1
before PCI, %
96 100 0.078 83 86 0.056
Multivessel diseases, % 71 69 0.76 61 74 <0.0001
IIb/IIIa inhibitors, % 36 44 0.11 35 54 <0.0001
L
SConclusions: Use of IABP in patients with AMI and CS seems to be beneﬁcial when
primary PCI is unsuccessful but may be harmful when PCI is successful in restoring
patency of the infarct related artery.
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Impact of arterial access on all cause mortality in octogenarians, following
Primary Percutaneous Intervention (PPCI) for ST elevation myocardial
infarction (STEMI): Insights from Glenﬁeld-Leicester UK ACS registry.
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Background: The burden of cardiovascular disease is higher amongst Octogenarians
(OG). Increasing numbers of OGs are undergoing Primary Percutaneous Intervention
(PPCI) for ST elevation myocardial infarction (STEMI) against a background of
potential excess risks associated with the procedure. There is very limited long-term
outcome data available in this patient population.
Methods: Objective: To analyze one year all-cause mortality in OGs who were
admitted with a STEMI and received PPCI in a tertiary cardiac centre in the UK and to
observe the impact of vascular access (Femoral vs. Radial) on mortality. Design: The
registry records of 2951 consecutive STEMI patients, age >50 years admitted between
2005-2011 were reviewed at patient-level data. One year all-cause mortality data was
obtained from the national MINAP-UK data base and collated with local registry
information. Kaplan-Meier and Cox regression analysis were used to compare
mortality between OG and age-group 50-79 years.
Results: Of the total population, 8.1 % (n¼241, Mean age:85.3yrs (SD:3.4) were
OG of whom 53.5% were male. Use of heparin, warfarin, bivalirudin, aspirin, andJACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT Abstrclopidogrel were comparable between groups. Use of femoral arterial access (63%)
was signiﬁcantly higher amongst OG (P¼0.04) compared to radial route. In univariate
analysis, event-free-survival (hazard ratio: 2.5 CI [1-6.1]) was signiﬁcantly lower in
OG compared to other age group (log rank test, P¼0.001). All-cause mortality was
signiﬁcantly higher amongst OG who had femoral arterial access compared to radial
route (log rank test, P¼0.03), but this was not apparent amongst 50-79 age group (log
rank, P¼0.06). In Cox regression analysis, after adjusting for gender, conventional
risk factors, anticoagulation and antiplatelet-use, femoral access remained signiﬁcantly
associated with one year all cause mortality (hazard ratio:2.8[1-7.3], P¼0.04).
Conclusions: OG who received PPCI for STEMI have disproportionately higher one
year all cause mortality compared to younger age group. Use of femoral arterial access
appears to be independently associatedwith this excessmortality. Radial access preferred
to be the safer option in this high risk population, to improve long term prognosis.
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Background: New-generation DES showed favourable outcomes in patients with
STEMI. We aim to assess mid- and long-term outcomes in STEMI patients treated
with Nobori, DES with bioresorbable polymer.
Methods: In 2 large, prospective, multi-center registries, out of 14134 enrolled
patients, 1302 patients with STEMI were treated with the Nobori DES. Mid-term and
long-term outcomes (up to 1 and 3 years) are available for 806 and 248 patients
respectively. Adverse events were adjudicated by CEC.
Results: STEMI patients were 6013y old, 79% males, 16% with prior MI and 10%
with prior coronary revascularizations. The pain-to-balloon time was <3 hours in
37.6%; >3 < 6 hours in 22.6%; > 6 < 12 hours in 12.8% and > 12 hours in 19.6% of
the patients. The median door-to-balloon time was 55 minutes. Lesions were complex
(61.9% B2/C), calciﬁed (25.5%), and containing thrombus (47.4%). Low perfusion
(TIMI 0/1) was observed in 43.8% of lesions before procedure, while after procedure
TIMI 3 was achieved in 96.0%. Most of the STEMIs had anterior (50%) or inferior
(39%) location. 43% of all STEMI patients received adjunctive treatment: either
hemodynamic support (9.0%), intravenous thrombolysis (15.7%), pre-procedural GP
IIB/IIIa inhibitor (9.9%), thrombus aspiration (26.1%) or other speciﬁc treatment
(14.9%). At 1 year, 8 patients died because of cardiac reasons (1.0%), 15 patients
suffered re-infarctions (1.9%) 19 patients underwent TLR (2.4%) and 9 (1.1%)
patients TVR. The TLF rate was 3.4%, while MACE rate was 4.3%. There were 9
(1.1%) deﬁnite or probable stent thromboses, of which 1 acute, 7 subacute and one late
ST. In the patient cohort followed at 3-year, 2 patients died from cardiac causes
(0.8%), 10 had re-infarction (4.0%) with a TLF rate of 6.1%. No patient suffered very
late stent thrombosis between 1- and 3-years follow-up.
Conclusions: Despite limitations of registry and potential bias in enrolling lower risk
patients our data show that treatment of STEMI patients with bioresorbable polymer
coated DES was associated with favorable mid- and long-term outcomes and low rate
of stent thrombosis. Those data, conﬁrm both efﬁcacy and safety of DES with bio-
resorbable polymer in this complex patient's subset.
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Background: The purpose of this observational study was to evaluate the effects of radial
artery access (RA) versus femoral artery access (FA) in octogenarians undergoing percu-
taneous coronary intervention (PCI) due to acute coronary syndrome, i.e. ST-elevation
myocardial infarction (STEMI) and unstable angina/non-STEMI (UA/NSTEMI).
Methods: Data were obtained from the SCAAR registry (Swedish Coronary Angi-
ography and Angioplasty Registry) for PCI procedures performed in Västra Götaland
region in Sweden between 2005-2011. We evaluated 30-days mortality in 1429
elderly patients  80 years of age. PCI was performed through RA in 542 patients and
through FA in 887 patients. The two groups were compared using Cox proportional
hazards regression with shared frailty to account for hierarchical database. Adjust-
ments for the differences in baseline characteristics were made with propensity score.
The following variables were included in the calculation of the propensity score: age,
gender, indication for PCI, smoking habits, hypertension, diabetes, hyperlipidaemia,
severity of coronary disease, previous infarction, previous PCI, previous coronary
artery by-pass surgery (CABG), anticoagulation therapy with glycoprotein IIb/IIIa
receptor antagonists (GP IIb/IIIa), bivalirudin, clopidogrel, unfractionated heparin
/low-molecular weight heparins (UH/LMWH), year, hospital.
Results: The mean age was 83.4  3.2 and 83.5  3.1 in the RA and FA group
respectively (p¼0.51). The two groups were balanced regarding gender, diabetes,acts/ORAL/STEMI and High Risk Patients B15
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Ssmoking habits, hypertension and hyperlipidaemia and in use of UH/LMWH and
drug-eluting stents during the procedure. RA patients were more likely to be pre-
treated with aspirin, clopidogrel and to receive bivalirudin. FA patients were more
likely to had previous myocardial infarction, previous PCI, previous coronary CABG
and to receive GP IIb/IIIa. There were 600 patients (41.1%) with STEMI and 858
(58.9%) with UA/NSTEMI. More patients with STEMI underwent PCI through FA.
There was no difference in 30-days mortality between the RA and FA group (5.5% vs.
6.3%; HR 1.2; 95% CI 0.73–2.0; p ¼ 0.46).
Conclusions: In this study, PCI through radial artery access was not associated with
reduced 30-days mortality in octogenarians with acute coronary syndromes. Properly
designed randomised clinical trial is needed to test whether radial artery access may
decrease mortality in octogenarians.
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Background: Treatment of complex lesions in coronary arteries with aneurysms,
ectasia, or tapering remains challenging due to a high risk of vessel wall-stent diameter
mismatch. The self-apposing STENTYS stent (STENTYS SA, Paris, France) is
designed to adjust to variable vessel diameters, which may optimize the vessel wall-
stent match and reduce the risk of stent malapposition. STENTYS is extensively
evaluated in ST-segment elevation myocardial infarction (STEMI) patients, but there
is a paucity of data of other treatment indications. We evaluated the feasibility and
safety of the STENTYS stent in complex lesions with a high risk of diameter
mismatch.
Methods: We included consecutive patients treated with STENTYS between April
2010 and June 2013 because of angiographic characteristics with a high risk of
diameter mismatch, including aneurysms, ectasia, tapering, bifurcation lesions, and
saphenous vein graft (SVG). STEMI patients were excluded. Angiographic success
was deﬁned as ﬁnal residual stenosis <5 % in the target vessel with TIMI 3 ﬂow.
Procedural success was deﬁned as angiographic success without in-hospital cardiac
death, myocardial infarction (MI) or target vessel revascularization (TVR).
Results: A total of 87 patients were included, mean age was 6512 years. Indications
for the STENTYS stent were; aneurysm: 25(29%), ectasia: 21(24%), tapering:
27(31%), bifurcation: 22(25%), and SVG: 9(10%). In some target vessels 2 indi-
cations applied. Angiographic and procedural success was achieved in 92% and 91%
respectively. In 6(8%) patients there was 5% residual stenosis on visual estimate,
which might improve over time due to the stents self-apposing properties, 1 patient
suffered from an in-hospital MI. No peri-procedural complications occurred.
Conclusions: Early angiographic and procedural success of treatment with the
STENTYS stent, in patients other than STEMI, are favourable. This single-center
experience provides novel insights of angiographic and procedural outcome in
complex lesions with a high risk of diameter mismatch. Long-term clinical follow-up,
which will be available at TCT, is needed to evaluate whether the self-apposing stent
technique translates into favourable clinical outcomes.
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Background: Soｍe trials have suggested that transradial intervention (TRI) reduces
vascular complications and bleeding compared with transfemoral intervention (TFI).
However, the long term outcomes are still not clear in patients with ST-segment
elevation myocardial infarction (STEMI). In this study, we aimed to assess the
feasibility and the long term outcomes of TRI in patients with who underwent primary
percutaneous coronary intervention (PCI).
Methods: This study was multicenter,retrospective observational study. Between
January 2006 and December 2010, a total of 550 STEMI patients underwent primary
PCI. Out of these patients, TRI was performed in 208 patients and TFI was performed
in 342 patients. Mean follow-up period was 3325 months. Outcome measures were
in-hospital complications (all-cause death,recurrent myocardial infarction,stroke,major
bleeding) and major adverse cardiovascular events (MACE: all-cause death,target
vessel revascularization (TVR), recurrent myocardial infarction, admission of heart
failure) at 3 years.
Results: There was no statistical difference in patients characteristics between two
groups. During the initial hospitalization, the complications rate was 2.9% in TRIB16 JACC Vol 62/18/Suppl B j October 27–Novembegroup and 9.4% in TFI group (P¼0.004). Kaplan-Meier survival curves showed that
the freedom from MACE was 76.9% in TRI vs 68.4% in TFI at three years(P¼0.03).Conclusions: Both the in-hospital complications and the difference in freedom from
MACE at 3 years were statistically lower in TRI group compared with TFI group.Miscellaneous Coronary Intervention
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Background: Percutaneous coronary intervention (PCI) in the setting of acute
myocardial infarction (MI) is known to predict stent thrombosis. However, the
association between the spectrum of clinical presentation and stent thrombosis after
PCI has not been well deﬁned. This study aims to compare the stent thrombosis rates
across the acuity of clinical presentation for PCI.
Methods: The study included a cohort of 12198 consecutive patients who underwent
PCI. Patients were categorized according to their clinical presentation: stable angina
pectoris (SAP, n¼3700), unstable angina pectoris (UAP, n¼2845), non ST-segment
elevation MI (NSTEMI, n¼4083), and ST-segment elevation MI (STEMI, n¼1570).
The ARC-deﬁned stent thrombosis rates were compared among the groups.
Results: Antiplatelet loading was similar across groups (85% overall). The use of
drug-eluting stents (DES) in STEMI pts. was 51.3%, 73% in NSTEMI, 77.4% in
UAP, and 77.7% in SAP. One-year deﬁnite stent thrombosis rates were highest in
STEMI compared to other groups. (Figure) Similarly, rates of probable stent throm-
bosis increased with the acuity of the clinical presentation: lowest in UAP and highest
in STEMI. The majority of deﬁnite (71.4%) and probable (66.6%) stent thrombosis
occurred early (within 30 days). The rates of death and myocardial infarction corre-
sponded with the acuity of clinical presentation.
Conclusions: In patients undergoing PCI, the acuity of clinical presentation corre-
sponds to an increase in the incidence of stent thrombosis. A pro-inﬂammatory milieu
promoting thrombosis and delaying endothelial healing may contribute to this.r 1, 2013 j TCT Abstracts/ORAL/Miscellaneous Coronary Intervention
